Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Skeletal Muscle|December 3, 2024
SIX transcription factors are necessary for the activation of DUX4 expression in facioscapulohumeral muscular dystrophyAmelia Fox, Jonathan Oliva, Rajanikanth Vangipurapu, et al.Scientific Reports|November 3, 2024
Temporal variation in p38-mediated regulation of DUX4 in facioscapulohumeral muscular dystrophyRajanikanth Vangipurapu, Jonathan Oliva, Amelia Fox, et al.The Journal of Biological Chemistry|September 18, 2017
Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesiclesJonathan Bruno, Nicola Pozzi, Jonathan Oliva, et al.Journal of Robotic Surgery|September 18, 2016
Ultrasonic thermal damage during robotic hysterectomyJason Massengill, Eric Lombardini, Jonathan Oliva, et al.Journal of Medicinal Chemistry|December 23, 2024
Discovery of an Orally Efficacious Pyrazolo[3,4-d]pyrimidine Benzoxaborole as a Potent Inhibitor of CryptosporidiumMakafui Gasonoo, Soumitra Guin, José E Teixeira, et al.The Journal of Pharmacology and Experimental Therapeutics|June 14, 2019
Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular DystrophyJonathan Oliva, Scott Galasinski, Amelia Richey, et al.Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in MiceBarbara Ulmasov, Brent A Neuschwander-Tetri, Jinping Lai, et al.Journal of Medicinal Chemistry|June 2, 2023
Structure-Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines againstTanner J Schubert, Edmund Oboh, Hannah Peek, et al.Skeletal Muscle|September 6, 2017
BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cellsAmy E Campbell, Jonathan Oliva, Matthew P Yates, et al.The Journal of Pharmacology and Experimental Therapeutics|February 25, 2016
Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory DiarrheaDavid W Griggs, Michael J Prinsen, Jonathan Oliva, et al.Pageof 2